Industry SectorsMarketsShire US$5.2bn Buy Leads M&A Deals in Pharma Sector

Shire US$5.2bn Buy Leads M&A Deals in Pharma Sector

A deal completed at the weekend that will see UK pharmaceutical company Shire acquire US biotech firm NPS Pharmaceuticals for US$5.2bn (£3.4bn) is the biggest of several agreed mergers and acquistions (M&As) in the sector.

The agreement comes two months after a takeover bid for Shire from US firm AbbVie was abandoned. The boards of both Shire and NPS have already approved the deal, which is expected to add to the UK company’s earnings from 2016.

“The acquisition of NPS Pharma is a significant step in advancing Shire’s strategy to become a leading biotechnology company,” said Shire’s chief executive officer (CEO), Flemming Ornskov.

“This is about growth and rare diseases, and it fits hand in glove with our strategy and our franchise,” he added.

Shire is paying US$46 (£30) a share in cash for NPS, which specialises in drugs for gastrointestinal disorders. The figure represents a 51% increase to the price at which NPS shares traded on 16 December, when speculation of a potential deal first emerged.

The announcement was followed by news of several smaller deals in the pharmaceuticals sector.

Swiss group Roche said it would buy a controlling stake in Foundation Medicine, a US molecular and genomic analysis company, in a US$1.18bn deal to strengthen

Roche’s development of personalised cancer therapies.

US group Johnson & Johnson agreed a licence deal with AC Immune of Switzerland worth up to US$509m, which will see the two companies join forces on potential treatments for Alzheimer’s disease.

US group Biogen Idec is to acquire the privately held UK company Convergence Pharmaceuticals, a specialist in chronic pain treatment that was spun out of GlaxoSmithKline in 2010.

Canada’s Tekmira Pharmaceuticals announced an agreed merger with US company OnCore Biopharma, in an all-paper deal to jointly develop treatments for hepatitis B. Reports put the implied market value of the merged company at around US$750m.

Related Articles

The trends set to define the fintech, banking and finance industry in 2020

Brexit The trends set to define the fintech, banking and finance industry in 2020

1m Pierre-Antoine Dusoulier
Frack attack: energy uncertainty and the need for agile credit risk

Credit Risk Frack attack: energy uncertainty and the need for agile credit risk

3m Ian Tobin
Finance functions must adapt to attract Generation Z talent

Financial Services Finance functions must adapt to attract Generation Z talent

7m Austin Clark
Financial professionals struggle to find time to combat stress

Financial Services Financial professionals struggle to find time to combat stress

2y The Global Treasurer
The Challenge of Building and Maintaining a Central Treasury Operation in a Decentralized Company

EEA The Challenge of Building and Maintaining a Central Treasury Operation in a Decentralized Company

2y BELLIN
The Treasury Challenge of a Post-Merger Integration

EEA The Treasury Challenge of a Post-Merger Integration

2y BELLIN
The Challenge of Integrating Worldwide Subsidiaries into one TMS

Baltics The Challenge of Integrating Worldwide Subsidiaries into one TMS

2y BELLIN
Q&A with BMG's treasury : BELLIN - We Love Treasury 2

EEA Q&A with BMG's treasury : BELLIN - We Love Treasury 2

2y BELLIN

Whitepapers & Resources

Transaction Banking Survey 2019

Transaction Banking Survey 2019

5m
TIS Sanction Screening Survey Report

Payments TIS Sanction Screening Survey Report

8m
Enhancing your strategic position: Digitalization in Treasury

Payments Enhancing your strategic position: Digitalization in Treasury

9m
Netting: An Immersive Guide to Global Reconciliation

Netting: An Immersive Guide to Global Reconciliation

1y